Audiological findings in patients treated with radiotherapy for head and neck tumors. 2010

Ana Helena Bannwart Dell'Aringa, and Myrian de Lima Isaac, and Gustavo Viani Arruda, and Alfredo Rafael Dell'Aringa, and Maria Carolina B N Esteves
Otolaryngology Program, Medical School of MarĂ­lia.

Radiotherapy has been widely used given its increase in the successful outcomes and cure of some cancers. OBJECTIVE To evaluate the functionality of the auditory system in patients who underwent radiotherapy treatment for head and neck tumors. METHODS From May 2007 to May 2008, otorhinolaryngological and audiological evaluation (Pure Tone Audiometry (air and bone conduction), Speech Audiometry, Tympanometry, Acoustic Reflex testing and Distortion Product Otoacoustic Emissions) were performed in 19 patients diagnosed with head and neck neoplasia and treated with radiotherapy. Prospective case series study. RESULTS 10.5% left ears and 26.3% right ears had bilateral hearing loss soon after radiotherapy according to ASHA criteria. CONCLUSIONS Radiotherapy treatment for head and neck cancer has ototoxic effects. Early programs of auditory rehabilitation should be offered to these patients.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011832 Radiation Injuries Harmful effects of non-experimental exposure to ionizing or non-ionizing radiation in VERTEBRATES. Radiation Sickness,Radiation Syndrome,Injuries, Radiation,Injury, Radiation,Radiation Injury,Radiation Sicknesses,Radiation Syndromes,Sickness, Radiation,Sicknesses, Radiation,Syndrome, Radiation,Syndromes, Radiation
D004307 Dose-Response Relationship, Radiation The relationship between the dose of administered radiation and the response of the organism or tissue to the radiation. Dose Response Relationship, Radiation,Dose-Response Relationships, Radiation,Radiation Dose-Response Relationship,Radiation Dose-Response Relationships,Relationship, Radiation Dose-Response,Relationships, Radiation Dose-Response
D006258 Head and Neck Neoplasms Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651) Cancer of Head and Neck,Head Cancer,Head Neoplasm,Head and Neck Cancer,Head and Neck Neoplasm,Neck Cancer,Neck Neoplasm,Neck Neoplasms,Neoplasms, Upper Aerodigestive Tract,UADT Neoplasm,Upper Aerodigestive Tract Neoplasm,Upper Aerodigestive Tract Neoplasms,Cancer of Head,Cancer of Neck,Cancer of the Head,Cancer of the Head and Neck,Cancer of the Neck,Head Neoplasms,Head, Neck Neoplasms,Neoplasms, Head,Neoplasms, Head and Neck,Neoplasms, Neck,UADT Neoplasms,Cancer, Head,Cancer, Neck,Cancers, Head,Cancers, Neck,Head Cancers,Neck Cancers,Neoplasm, Head,Neoplasm, Neck,Neoplasm, UADT,Neoplasms, UADT
D006309 Hearing The ability or act of sensing and transducing ACOUSTIC STIMULATION to the CENTRAL NERVOUS SYSTEM. It is also called audition. Audition
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Ana Helena Bannwart Dell'Aringa, and Myrian de Lima Isaac, and Gustavo Viani Arruda, and Alfredo Rafael Dell'Aringa, and Maria Carolina B N Esteves
June 2009, International journal of radiation oncology, biology, physics,
Ana Helena Bannwart Dell'Aringa, and Myrian de Lima Isaac, and Gustavo Viani Arruda, and Alfredo Rafael Dell'Aringa, and Maria Carolina B N Esteves
February 2013, Acta oncologica (Stockholm, Sweden),
Ana Helena Bannwart Dell'Aringa, and Myrian de Lima Isaac, and Gustavo Viani Arruda, and Alfredo Rafael Dell'Aringa, and Maria Carolina B N Esteves
July 2003, Japanese journal of clinical oncology,
Ana Helena Bannwart Dell'Aringa, and Myrian de Lima Isaac, and Gustavo Viani Arruda, and Alfredo Rafael Dell'Aringa, and Maria Carolina B N Esteves
June 2016, JAMA oncology,
Ana Helena Bannwart Dell'Aringa, and Myrian de Lima Isaac, and Gustavo Viani Arruda, and Alfredo Rafael Dell'Aringa, and Maria Carolina B N Esteves
January 2019, La Clinica terapeutica,
Ana Helena Bannwart Dell'Aringa, and Myrian de Lima Isaac, and Gustavo Viani Arruda, and Alfredo Rafael Dell'Aringa, and Maria Carolina B N Esteves
March 2015, Chemical senses,
Ana Helena Bannwart Dell'Aringa, and Myrian de Lima Isaac, and Gustavo Viani Arruda, and Alfredo Rafael Dell'Aringa, and Maria Carolina B N Esteves
September 2020, Oral diseases,
Ana Helena Bannwart Dell'Aringa, and Myrian de Lima Isaac, and Gustavo Viani Arruda, and Alfredo Rafael Dell'Aringa, and Maria Carolina B N Esteves
February 2007, International journal of radiation oncology, biology, physics,
Ana Helena Bannwart Dell'Aringa, and Myrian de Lima Isaac, and Gustavo Viani Arruda, and Alfredo Rafael Dell'Aringa, and Maria Carolina B N Esteves
February 2021, Journal of clinical medicine,
Ana Helena Bannwart Dell'Aringa, and Myrian de Lima Isaac, and Gustavo Viani Arruda, and Alfredo Rafael Dell'Aringa, and Maria Carolina B N Esteves
January 2017, Hellenic journal of nuclear medicine,
Copied contents to your clipboard!